Related Experiment Video
Updated: Sep 3, 2025
An R-Based Landscape Validation of a Competing Risk Model
Published on: September 16, 2022
Predicting complications of spine surgery: external validation of three models
Martin Coia Jadresic1, Joseph F Baker2
1Department of Orthopaedic Surgery, Waikato Hospital, Hamilton, 3204, New Zealand.
Background Context:
Numerous prediction tools are available for estimating postoperative risk following spine surgery. External validation and comparison of these tools is critical prior to clinical use. No model for adverse events after spine surgery has undergone decision curve analysis.
Purpose:
External validation, comparison, and decision curve analysis of 3 previously described models [SpineSage, Risk Assessment Tool (RAT), National Surgical Quality Improvement Program Risk Calculator (NSQIP)] for predicting 30-day postoperative complications after spine surgery STUDY DESIGN: Retrospective cohort study.
Patient Sample:
Three hundred fifteen patients who underwent spine surgery at a tertiary academic surgical center in New Zealand between January 2019 and April 2020.
Outcome Measures:
As defined by each risk prediction tool and objectively using the Comprehensive Complication Index.
Methods:
We retrospectively reviewed risk of postoperative complication was calculated for each patient according to the 3 models. Overall model fit, calibration, discrimination, and decision curve analysis for each model were assessed in line with the transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD) guidelines.
Results:
100 (35%) patients experienced complications. SpineSage and RAT were well calibrated, NSQIP systematically underestimated risk. Area under the curve was greatest for SpineSage (0.75) compared with the NSQIP (0.72) and the RAT (0.69). Decision curve analysis showed SpineSage resulted in greatest net benefit across all risk thresholds.
Conclusions:
Of the models studied, SpineSage most accurately predicted risk and can be expected to perform better than a strategy of treating all patients if patient or surgeon deem complication risk >10% significant. NSQIP may not be suitable for the clinical use in our local population.
